Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners
DEPT OF DEFENSE
Place of performance: Frederick, MD
- Posted
- Jan 11, 2026
- Closes
- Oct 18, 2028 (in 780 days)
Similar opportunities open now
- Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersSame funderOpenDEPT OF DEFENSECloses Oct 2028
- . Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersSame funderOpenDEPT OF DEFENSECloses Oct 2028
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBSame funderOpenDEPT OF DEFENSECloses Jun 2027
- JPEO-CBRND CWMD BOTAA-24-01Same funderOpenDEPT OF DEFENSECloses Feb 2029
- AUTONOMOUS DELIVERY OF PRECISION NEUTRALIZATION OF EXPLOSIVE HAZARDSSame funderOpenDEPT OF DEFENSECloses Dec 2026
At a glance
This is a government contract opportunity posted by DEPT OF DEFENSE in the research and development in the physical category. The deadline is October 18, 2028, 781 days from now. Work is performed in Frederick, MD.
Classification and identifiers
- Industry (NAICS)
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
- Product or service (PSC)
- National Defense R&D Services; Department of Defense - Military; Experimental Development (AC13)
- Solicitation number
- W911SR-25-S-GUIDE
- Contracting office
- W6QK ACC-APG
Who can apply
About this opportunity
W911SR-25-S-GUIDE Notice Type: Special Announcement Synopsis: This is a solicitation for parties interested in participating in projects sought by the The Joint Project Lead Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies (JPL-CBRND-EB) (JPL EB). JPL EB has the mission to accelerate the delivery of medical countermeasures to the warfighter through the development and implementation of platform systems. Generative Unconstrained Intelligence Drug Engineering (GUIDE) is an integrated computational and experimental platform designed to accelerate medical countermeasure development. GUIDE harnesses the power of advanced simulation and machine learning to enable preparedness and facilitate rapid response to protect the warfighter from a diverse and dynamic threat...